These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7670167)

  • 21. T-lymphocyte adhesion and immunointervention in transplantation.
    Fischer A
    Adv Nephrol Necker Hosp; 1991; 20():305-11. PubMed ID: 2063719
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-CD4 therapy induces a donor-specific, organ-nonspecific tolerance in allogeneic kidney graft recipients.
    Kuttler B; Lehmann M; Lacha J; Brock J; Hahn HJ
    Transplant Proc; 1994 Apr; 26(2):728-9. PubMed ID: 8171628
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-CD4 IgG2a monoclonal antibody treatment prevents the expansion of T cells in the spleen during murine graft-vs-host disease.
    Noort WA; Benner R; Savelkoul HF
    Transplant Proc; 1995 Feb; 27(1):384-6. PubMed ID: 7879030
    [No Abstract]   [Full Text] [Related]  

  • 24. Tolerance induction against cardiac allograft by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation.
    Isobe M; Ihara A
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1079-80. PubMed ID: 8095106
    [No Abstract]   [Full Text] [Related]  

  • 25. Therapeutic applications of anti-CD4 antibodies.
    Olive D; Mawas C
    Crit Rev Ther Drug Carrier Syst; 1993; 10(1):29-63. PubMed ID: 8472311
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-CD4 monoclonal antibody treatment in hamster-to-rat cardiac transplantation: cytotoxic antidonor antibodies detected by a new flow cytometric complement-dependent cytotoxicity assay.
    Steinbrüchel DA; Lillevang ST; Nielsen B; Kemp E
    Transplant Proc; 1993 Feb; 25(1 Pt 1):427-9. PubMed ID: 8438364
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of anti-CD4, anti-NC, and anti-NK monoclonal antibody on the survival of cardiac xenografts and allografts in mice.
    Yang L; Mottram PL; Han WR; Smart YC
    Transplant Proc; 1995 Jun; 27(3):2185-6. PubMed ID: 7792927
    [No Abstract]   [Full Text] [Related]  

  • 28. A short course of cyclosporin A combined with anti-CD4 and/or anti-TCR MAb treatment induces long-term acceptance of kidney allografts in the rat.
    Lácha J; Chadimová M; Havlícková J; Brock J; Matl I; Volk HD; Lehmann M
    Transplant Proc; 1995 Feb; 27(1):125-6. PubMed ID: 7878869
    [No Abstract]   [Full Text] [Related]  

  • 29. [Advances in immunossuppression in liver transplantation].
    Olivera-Martínez MA
    Rev Invest Clin; 2005; 57(2):237-43. PubMed ID: 16524064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The evolution and future of immunosuppression in renal transplantation.
    Goral S; Helderman JH
    Semin Nephrol; 1997 Jul; 17(4):364-72. PubMed ID: 9241720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nondepleting anti-CD4 antibodies in transplantation. Evidence that modulation is far less effective than prolonged CD4 blockade.
    Darby CR; Bushell A; Morris PJ; Wood KJ
    Transplantation; 1994 May; 57(10):1419-26. PubMed ID: 8197600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC; Tibbe GJ; Noort WA; Bril-Bazuin C; Benner R; Savelkoul HF
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stability of tolerance in mice generated by CD4 and CD8 monoclonal antibody treatment: cell transfer experiments.
    Chen Z; Cobbold S; Waldmann H; Metcalfe S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):790-1. PubMed ID: 8438482
    [No Abstract]   [Full Text] [Related]  

  • 34. CD4 and CD25 monoclonal antibody cocktail in kidney transplant rejection prophylaxis: clinical results of a pilot study.
    Mousson C; Tanter Y; Racadot E; Wijdenes J; Chalopin JM; Chevet D; Hervé P; Rifle G
    Transplant Proc; 1995 Apr; 27(2):1727-8. PubMed ID: 7725472
    [No Abstract]   [Full Text] [Related]  

  • 35. Combined monoclonal antibody therapy in experimental small bowel transplantation.
    Bowles MJ; Wood RF; Pockley AG
    Transplant Proc; 1996 Oct; 28(5):2510. PubMed ID: 8907926
    [No Abstract]   [Full Text] [Related]  

  • 36. Prolongation of human pancreatic islet xenografts by pretreatment of islets with anti-human ICAM-1 monoclonal antibody.
    Zeng Y; Torres MA; Thistlethwaite JR; Montag A; Bluestone JA
    Transplant Proc; 1994 Jun; 26(3):1120. PubMed ID: 7913254
    [No Abstract]   [Full Text] [Related]  

  • 37. New immunosuppressive therapies in renal transplantation: monoclonal antibodies.
    Buhaescu I; Segall L; Goldsmith D; Covic A
    J Nephrol; 2005; 18(5):529-36. PubMed ID: 16299678
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Orthotopic human lung carcinoma xenografts in BALB/c mice immunosuppressed with anti-CD4 monoclonal antibodies and chronic alcohol consumption.
    Hunt JD; Robert EG; Zieske AW; Bautista AP; Bukara M; Lei D; Shellito JE; Nelson S; Kolls JK; Skrepnik N
    Cancer; 2000 Jan; 88(2):468-79. PubMed ID: 10640982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppression: monoclonal antibodies.
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):242-75. PubMed ID: 3347952
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic immunosuppression of T cells.
    Waldmann H; Cobbold SP; Wraith D; Isaacs J
    Curr Opin Biotechnol; 1992 Dec; 3(6):668-74. PubMed ID: 1369123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.